Search Results

Enzolytics, Inc. announces a collaboration with Abveris, a division of Twist Bioscience Corporation, to discover fully human monoclonal antibodies against multiple viruses.

The Business Intelligence Group today announced that it has awarded Abveris a division of Twist Bioscience, a Best Places to Work 2022.

Abveris today announced that Prometheus Biosciences and Abveris have entered a multi-year collaboration to develop therapeutic antibodies against multiple targets.

Twist Bioscience Corporation today announced it entered into a definitive agreement to acquire Abveris.

Twist Bioscience snapped up in vivo antibody discovery company Abveris Inc. in a deal valued at up to $190 million. The acquisition is expected to bolster Twist’s biopharma antibody capabilities.

Abveris, Inc. (“Abveris”) announced today that it has entered into an antibody discovery partnership with Foundery Innovations, Inc. (“Foundery Innovations”) for the discovery of monoclonal antibodies to support the development of novel biotherapeutic drugs.

Abveris, Inc. (“Abveris”) and Abilita Bio, Inc. announce a joint research collaboration that will leverage the synergies between their platforms to enable the discovery of novel antibodies targeting key GPCRs within the tumor immune microenvironment.

Abveris, Inc. (“Abveris”) announced today that it has entered into an antibody discovery partnership with Saccharo, Inc. (“Saccharo”) for the discovery of monoclonal antibodies to advance the Saccharo therapeutic pipeline

Abveris, Inc., Boston’s leader in antibody discovery services, today announced the deployment of a second Berkeley Lights, Inc. Beacon® optofluidic system to enable expansion of the Abveris antibody discovery offering.

Abveris, Inc. (“Abveris”) announced today that it has entered into an agreement with Immunitas Therapeutics, Inc. (“Immunitas”) for the discovery of monoclonal antibodies to expand the Immunitas therapeutic pipeline. Under the terms of the agreement, Abveris will utilize its proprietary DiversimAb TM mouse model in combination with